Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model

BACKGROUND: Tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccination during adolescence was introduced in response to the resurgence of pertussis in various countries. A new Tdap vaccine was manufactured in Korea as a countermeasure against a predicted Tdap vaccine shortage. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Hyo Jin, Han, Seung Beom, Kim, Bo Ram, Kang, Kyu Ri, Huh, Dong Ho, Choi, Gi Sub, Ahn, Dong Ho, Kang, Jin Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381055/
https://www.ncbi.nlm.nih.gov/pubmed/28376777
http://dx.doi.org/10.1186/s12879-017-2369-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381055/
https://www.ncbi.nlm.nih.gov/pubmed/28376777
http://dx.doi.org/10.1186/s12879-017-2369-x

Ejemplares similares